Pulmonologists and critical care experts will discuss the current evidence for interventions to improve outcomes in patients with severe ARDS during a Monday morning session chaired by Daniel Ouellette, MD, MS, FCCP.
Experts from CHEST and the American Thoracic Society (ATS) will discuss what causes bronchiectasis, new ways to screen for the condition, and novel therapies to treat it. The Monday morning session will be co-moderated by CHEST President, Doreen J. Addrizzo-Harris, MD, FCCP.
During a Monday afternoon session, presenters will consider how COPD impacts specific populations and how clinicians can do a better job helping those patients, said Session Co-Chair, Barry Make, MD, FCCP.
Speakers will categorize pulmonary symptoms and etiologies, assess sleep disruptions and disorders, and analyze important perioperative and critical issues in the care of transgender patients, said Session Co-Chair, Adan (Adam) Mora Jr., MD, FCCP.
Recent asthma care guidelines that recommend single maintenance and reliever therapy (SMART) and allergen immunotherapy in select patients will be the subject of Sunday morning debates co-chaired by Mary Cataletto, MD, FCCP.
A panel discussion on Sunday morning, co-chaired by Akram Khan, MD, MBBS, FCCP, will explore the clinical implications of a recent CHEST guideline intended to facilitate easier management of complex neuromuscular disease processes.
A Sunday morning panel chaired by Nathan Nowalk, MD, will review evidence and recommendations for shift workers, travelers with jet lag, and health care professionals who routinely experience circadian rhythm interruption.